Manufacturer: New Zealand Medical and Scient manufactures Ethinyloestradiol.


The uses of Ethinyloestradiol include:

Postmenopausal symptoms due to oestrogen deficiency including prevention of postmenopausal osteoporosis. In women with an intact uterus the addition of a progestogen is essential.

Treatment of metastatic breast cancer in postmenopausal women.

Treatment of prostatic cancer.

Dosage and Administration

This will depend on the particular indication used, but treatment should be undertaken with as low a dose as possible and for as short a period as is necessary.

Menopausal symptoms: 0.01-0.05mg daily.

Osteoporosis: 0.02-0.05mg daily.

Prostatic and mammary carcinoma: 1-2mg daily.